SIF

Poster Session Abstracts
P-XVI - Osteoarticular Pharmacology; Pharmacology of Inflammation (II); Immunopharmacology


17 β-ESTRADIOL (E2) DIFFERENTLY AFFECTS OSTEOGENIC DIFFERENTIATION OF MESENCHYMAL STEM CELLS FROM BONE MARROW AND ADIPOSE TISSUE
Niada S., Ferreira L., Arrigoni E., Brini A.
EFFICACY OF LOW DOSES OF TYPE II COLLAGEN IN A RAT RHEUMATHOID ARTHRITIS MODEL: RELEVANCE OF ORAL TOLERANCE
Di Cesare Mannelli L., Micheli L., Baptista De Souza D., Cinci L., Zanardelli M., Ghelardini C.
ANTI-INFLAMMATORY AND ANTINOCICEPTIVE EFFECTIVENESS OF PALMITOYLETHANOLAMIDE IN A RAT MODEL OF OSTEOARTHRITIS: A COMPARISON WITH NIMESULIDE AND ACETAMINOPHEN
Donvito G., Comelli F., Costa B.
PRELIMINARY STUDY OF CALCIUM BALANCE AND BONE MINERALIZATION IMPROVEMENT BY A NEW CALCIUM SUPPLEMENT IN GROWING RATS
Flammini L., Vivo V., Bertoni S., Ballabeni V., Bettini R., Salomi E., Ghirri A., Bignetti E., Barocelli E.
PHARMACOLOGICAL CHARACTERIZATION OF THE GHRELIN RECEPTOR MEDIATING ITS PROTECTIVE EFFECT AGAINST OXIDATIVE STRESS IN OSTEOBLAST-LIKE MC3T3-E1 CELLS.
Dieci E., Pagani F., Casati L., Sibilia V.
PROPYLTHIOURACIL PREVENTS CUTANEOUS AND PULMONARY FIBROSIS IN THE REACTIVE OXYGEN SPECIES MURINE MODEL OF SYSTEMIC SCLEROSIS
Bitto A., Pizzino G., Irrera N., Bagnato G., Altavilla D., Squadrito F.
ROLE OF 5-HT IN INTESTINAL ISCHEMIA-REPERFUSION: SUPPRESSION OF INFLAMMATORY EVENTS BY 5-HT1A BLOCKADE IN MICE
Vivo V., Arcaro V., Rapalli A., Bertoni S., Flammini L., Saccani F., Vegezzi G., Ballabeni V., Barocelli E.
EFFECTS OF TOPICAL NSAIDS ON LPS-INDUCED INFLAMMATION
Torrisi S., Platania C., Drago F., Salomone S., Bucolo C.
EFFECTS OF ISCHAEMIC POSTCONDITIONING ON THE EARLY AND LATE TESTICULAR DAMAGE AFTER EXPERIMENTAL TESTIS ISCHAEMIA-REPERFUSION
Minutoli L., Irrera N., Squadrito F., Marini H., Bitto A., Arena S., Romeo C., Antonuccio P., Altavilla D.
ANTI-PYROPTOTIC EFFECTS OF DIMETHYL FUMARATE: AN IN VITRO STUDY
Miglio G., Rogazzo M., Fantozzi R.
LIVER X RECEPTORS (LXRS) ACTIVATION DECREASES NEUROINFLAMMATION IN PARKINSON’S DISEASE
Campolo M., Paterniti I., Siracusa R., Cuzzocrea S., Esposito E.
INTRAVITREAL INJECTION OF RESOLVIN D1 COUNTERACTS THE OCULAR DAMAGE INDUCED BY SYSTEMIC LPS IN A MURINE MODEL OF ENDOTOXIC UVEITIS
Gesualdo C., Rossi S., Di Filippo C., Maisto R., Ferraraccio F., Simonelli F., D'Amico M.
OCULAR ANTI-ALLERGIC ACTION OF MAPRACORAT, A NOVEL SELECTIVE GLUCOCORTICOID RECEPTOR AGONIST, INVOLVES EOSINOPHIL’S APOPTOSIS
Baiula M., Bedini A., Carbonari G., Dattoli S., Govoni P., Cavet M., Spampinato S.
ANTI-INFLAMMATORY EFFECTS OF INDICAXANTHIN FROM CACTUS PEAR FRUIT (OPUNTIA FICUS INDICA L, MILL.) IN CARRAGEENIN-INDUCED ACUTE INFLAMMATION IN RATS.
Panza E., De Cicco P., Allegra M., Livrea M., Cirino G., Ianaro A.
ANTI-INFLAMMATORY ACTIVITY OF TRITERPENOID CONJUGATES ON HUMAN MONOCYTES/MACROPHAGES: EVALUATION OF ANTI-OXIDANT ACTIVITY, PPARGAMMA EXPRESSION, AND NF-KAPPAB ACTIVATION.
Del Prete D., Bardelli C., Avonto C., Appendino G., Brunelleschi S., Fresu L.
MORPHINE MEDIATES A PROINFLAMMATORY PHENOTYPE VIA µ-OPIOID RECEPTOR-PKCε-AKT-ERK1/2 SIGNALLING PATHWAY IN ACTIVATED MICROGLIAL CELLS
Merighi S., Gessi S., Varani K., Fazzi D., Stefanelli A., Borea P.
A1 AND A3 ADENOSINE RECEPTORS INHIBIT LPS-INDUCED HYPOXIA-INDUCIBLE FACTOR-1 ACCUMULATION IN HYPOXIC MURINE ASTROCYTES
Gessi S., Merighi S., Stefanelli A., Fazzi D., Varani K., Borea P.
ACTIVITY OF MONOMERIC SMAC MIMETIC COMPOUND ON HUMAN FIBROBLAST LIKE SYNOVIOCYTES FROM RHEUMATOID ARTHRITIS PATIENTS
Lattuada D., Casnici C., Crotta K., Seneci P., Marelli O.
PERTHAMIDE C INHIBITS ENOS AND INOS EXPRESSION AND HAS IMMUNOMODULATING ACTIVITY INVIVO.
Vellecco V., Bucci M., Cantalupo A., Panza E., Zampella A., Ianaro A., Cirino G.
MYCOPHENOLIC ACID AUC ESTIMATION IN PATIENTS WITH LUPUS NEPHRITIS USING AN ALGORITHM VALIDATED IN AN HEART TRANSPLANTED POPULATION
Cojutti P., Franceschi L., Tursi V., Livi U., Zabotti A., Sacco S., Quartuccio L., De Vita S., Baraldo M.
PHARMACOLOGICAL MODULATION OF MACROPHAGE ACTIVATION PHENOTYPES: THE PARADIGM OF DEXAMETHASONE.
Tedesco S., Toniolo A., Bolego C., Cignarella A.
GENDER RELATED DIFFERENCES IN EXPRESSION OF DOPAMINERGIC RECEPTORS ON HUMAN CIRCULATING CD4+ T CELL SUBSETS
Kustrimovic N., Rasini E., Legnaro M., Dongmo B., Marino F., Cosentino M.
CHARACTERIZATION OF MONOCYTES AND MACROPHAGES IN RHEUMATOID ARTHRITIS PATIENTS: THEIR ROLE IN THE THERAPY RESPONSE.
Sola D., Amoruso A., Camaschella G., Michelone D., Rossi L., Sainaghi P., Pirisi M., Brunelleschi S.
A2B ADENOSINE RECEPTOR ENHANCES MELANOMA GROWTH AND IMMUNE SUPPRESSION MEDIATED BY MYELOID-DERIVED SUPPRESSOR CELLS.
Pinto A., Iannone R., Morello S.
EXPRESSION AND LOCALIZATION OF ADRENOMEDULLIN AND ITS RECEPTOR RAMP2 IN HUMAN THYMUS
Paliuri G., De Martin S., Bova S.
IL-1ß CONDITIONS LEUKEMIA AND LYMPHOMA CELL PROLIFERATION.
Sorrentino R., Terlizzi M., Pinto A.
PRECOCIOUS INVOLVEMENT OF PROKINETICIN SYSTEM IN DIABETIC NEUROPATHIC PAIN IN MICE
Castelli M., Moretti S., Franchi S., Balboni G., Lattanzi R., Negri L., Panerai A., Sacerdote P.
IDO-TARGETING INTERVENTION IN AUTOIMMUNE DIABETES BY PROTEASOME INHIBITION
Orabona C., Volpi C., Fallarino F., Belladonna M., Pallotta M., Vacca C., Bianchi R., Grohmann U., Puccetti P.